School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, Beijing, China.
J Nucl Med. 2024 Jan 2;65(1):87-93. doi: 10.2967/jnumed.123.266005.
This study aimed to assess the accuracy of intraprostatic tumor volume measurements on prostate-specific membrane antigen-targeted F-DCFPyL PET/CT made with various segmentation methods. An accurate understanding of tumor volumes versus segmentation techniques is critical for therapy planning, such as radiation dose volume determination and response assessment. Twenty-five men with clinically localized, high-risk prostate cancer were imaged with F-DCFPyL PET/CT before radical prostatectomy. The tumor volumes and tumor-to-prostate ratios (TPRs) of dominant intraprostatic foci of uptake were determined using semiautomatic segmentation (applying SUV percentage [SUV%] thresholds of SUV30%-SUV70%), adaptive segmentation (using adaptive segmentation percentage [A%] thresholds of A30%-A70%), and manual contouring. The histopathologic tumor volume (TV-Histo) served as the reference standard. The significance of differences between TV-Histo and PET-based tumor volume were assessed using the paired-sample Wilcoxon signed-rank test. The Spearman correlation coefficient was used to establish the strength of the association between TV-Histo and PET-derived tumor volume. Median TV-Histo was 2.03 cm (interquartile ratio [IQR], 1.16-3.36 cm), and median TPR was 10.16%. The adaptive method with an A40% threshold most closely determined the tumor volume, with a median difference of +0.19 (IQR, -0.71 to +2.01) and a median relative difference of +7.6%. The paired-sample Wilcoxon test showed no significant difference in PET-derived tumor volume and TV-Histo using A40%, A50%, SUV40%, and SUV50% threshold segmentation algorithms ( > 0.05). For both threshold-based segmentation methods, use of higher thresholds (e.g., SUV60% or SUV70% and A50%-A70%) resulted in underestimation of tumor volumes, and use of lower thresholds (e.g., SUV30% or SUV40% and A30%) resulted in overestimation of tumor volumes relative to TV-Histo and TPR. Manual segmentation overestimated the tumor volume, with a median difference of +2.49 (IQR, 0.42-4.11) and a median relative difference of +130%. Segmentation of intraprostatic tumor volume and TPR with an adaptive segmentation approach most closely approximates TV-Histo. This information might be used to guide the primary treatment of men with clinically localized, high-risk prostate cancer.
这项研究旨在评估使用不同分割方法在前列腺特异性膜抗原靶向 F-DCFPyL PET/CT 上进行前列腺内肿瘤体积测量的准确性。准确了解肿瘤体积与分割技术之间的关系对于治疗计划至关重要,例如辐射剂量体积确定和反应评估。 25 名患有临床局限性高危前列腺癌的男性在根治性前列腺切除术前接受 F-DCFPyL PET/CT 成像。使用半自动分割(应用 SUV30%-SUV70%的 SUV 百分比 [SUV%]阈值)、自适应分割(应用 A30%-A70%的自适应分割百分比 [A%]阈值)和手动轮廓测定法确定优势前列腺内摄取灶的肿瘤体积和肿瘤与前列腺比值(TPR)。组织病理学肿瘤体积(TV-Histo)作为参考标准。使用配对样本 Wilcoxon 符号秩检验评估 TV-Histo 与基于 PET 的肿瘤体积之间差异的显著性。Spearman 相关系数用于建立 TV-Histo 与 PET 衍生肿瘤体积之间关联的强度。 中位 TV-Histo 为 2.03cm(四分位距 [IQR],1.16-3.36cm),中位 TPR 为 10.16%。具有 A40%阈值的自适应方法最能准确确定肿瘤体积,中位差异为+0.19(IQR,-0.71 至+2.01),中位相对差异为+7.6%。配对样本 Wilcoxon 检验显示,使用 A40%、A50%、SUV40%和 SUV50%阈值分割算法时,基于 PET 的肿瘤体积与 TV-Histo 之间无显著差异(>0.05)。对于基于阈值的分割方法,使用更高的阈值(例如,SUV60%或 SUV70%和 A50%-A70%)会导致肿瘤体积低估,而使用更低的阈值(例如,SUV30%或 SUV40%和 A30%)会导致肿瘤体积相对于 TV-Histo 和 TPR 高估。手动分割高估了肿瘤体积,中位差异为+2.49(IQR,0.42-4.11),中位相对差异为+130%。 使用自适应分割方法对前列腺内肿瘤体积和 TPR 进行分割最接近 TV-Histo。这些信息可能有助于指导具有临床局限性高危前列腺癌的男性的主要治疗。